AI Advances in Breast Cancer Detection and Treatment
- Surviving Breast Cancer

- 4 minutes ago
- 4 min read
Artificial intelligence may help doctors detect breast cancer earlier, understand each diagnosis more clearly, and recommend more personalized care.
SurvivingBreastCancer.org Editorial EDUCATION | BREAST CANCER TREATMENT

Key Takeaways
AI-assisted mammograms can help radiologists detect more breast cancers without increasing false alarms.
New AI tools may help predict a person’s future breast cancer risk.
Digital pathology can give doctors additional information when planning treatment.
AI supports medical professionals rather than replacing their expertise.
Careful testing, human oversight, and patient support remain essential.
Healthcare changes rapidly, but few fields move as fast as artificial intelligence (AI) in modern medicine.
As of August 2026, artificial intelligence has moved beyond experimental promise in breast cancer care. Stronger evidence shows that AI can help radiologists find cancer earlier, estimate future risk, and give oncologists more information when they plan treatment. Doctors still make the decisions, but AI can serve as an additional set of eyes to review complex images and clinical data quickly.
AI-Supported Mammograms Are Finding More Cancers Earlier
A Swedish study of more than 105,000 women found that AI-supported mammogram screening helped radiologists detect 29% more breast cancers than traditional screening.
The AI-supported process detected about 81% of breast cancers, compared with about 74% using the standard approach. It found more cancers without increasing false alarms, which occur when a mammogram appears suspicious but follow-up testing does not find cancer. AI also reduced radiologists’ screening workload by about 44%, allowing them to spend more time reviewing the mammograms most likely to show signs of cancer.
Women whose mammograms received AI support had 12% fewer interval cancers, or cancers diagnosed after a normal mammogram but before the next scheduled screening. Researchers also found fewer invasive, large, and aggressive cancers in the AI-supported group, suggesting that AI may help radiologists detect some serious breast cancers sooner.
AI does not replace radiologists. Instead, it can act as an additional tool that helps them notice possible warning signs, prioritize higher-risk mammograms, and find some cancers sooner.
AI May Help Predict Future Breast Cancer Risk
New AI tools can examine subtle mammogram patterns that traditional risk assessments may miss. In July 2025, the Food and Drug Administration (FDA) granted Breakthrough Device designation to Prognosia Breast, a tool developed through Washington University School of Medicine in St. Louis. It uses mammogram images and a patient’s age to estimate the risk of developing breast cancer within five years. WashU Medicine reports that developers trained the model on tens of thousands of screening exams and found that it predicted risk more accurately than a standard questionnaire-based method.
The designation does not mean the FDA has approved or cleared the tool. It allows an expedited review process. With further testing in diverse populations, AI-based risk scores could help doctors personalize screening, prevention, and follow-up care.
Digital Pathology Is Supporting Treatment Decisions
AI can analyze digital images of biopsy or surgical tissue alongside clinical information. In May 2026, the FDA cleared ArteraAI Breast for people with early-stage, hormone receptor-positive, HER2-negative invasive breast cancer. The tool estimates whether a patient has a low or high risk of cancer spreading to distant parts of the body.
The score doesn’t select a treatment, but it gives doctors more information when discussing chemotherapy, hormone therapy, and other options. Early research also suggests that it may help identify some patients who could benefit from chemotherapy, although more evidence is needed.
AI Is Connecting More Types of Medical Data
Researchers are developing multimodal AI systems that combine medical images with other health information, such as pathology reports, laboratory results, medical histories, and clinical notes. By reviewing several types of information together, these tools may help doctors predict cancer outcomes, estimate the risk of recurrence, and determine which treatments may work best for individual patients. However, researchers still need to test and validate these systems carefully before doctors can use them widely in patient care.
Human Oversight Still Matters
Researchers continue to study whether AI works safely in everyday care. The large US PRISM trial will examine whether AI-assisted mammogram review improves cancer detection and reduces unnecessary callbacks.
AI won’t replace mammograms, biopsies, or medical professionals. Instead, it may help care teams recognize important patterns sooner and make more personalized decisions.
Hope Powered by Innovation and Community
AI may help doctors detect breast cancer earlier, understand each diagnosis more clearly, and recommend more personalized care. However, even the most advanced technology can’t replace compassionate guidance, trustworthy information, or the reassurance of connecting with people who understand the breast cancer experience.
Whether you’re newly diagnosed with breast cancer, navigating survivorship, living with MBC, or supporting someone you love, SurvivingBreastCancer.org helps bridge the space between medical care and everyday life. We provide programs, including virtual support groups, as well as trusted educational resources and podcasts featuring professionals, advocates, and caregivers.
Your support helps SurvivingBreastCancer.org continue providing knowledge, connection, and community to those impacted by breast cancer, every day, all year long.
This article is intended for educational purposes and is not a substitute for personalized medical advice. Treatment approvals, guidelines, and research continue to evolve. Always discuss testing, medications, side effects, and treatment decisions with your oncology team.
Read More:
On the Podcast: Breast Cancer Conversations
Why Are Women Still Waiting Months for Breast Cancer Answers? With Dr. Ryan Polselli










